Northwell Health

Pathway to Cures Announces Venture Investment in Five Liters

Retrieved on: 
Monday, October 16, 2023
Research, General Health, Pharmaceutical, Philanthropy, Fund Raising, Foundation, Clinical Trials, Science, Biotechnology, Other Philanthropy, Other Science, Health, VNS, MBA, Doctor of Philosophy, Litre, Indian Council of Medical Research, Bleeding, Anemia, Sickle cell disease, MD, Northwell Health, Injury, Von Willebrand disease, VWD, Electricity, Vagus nerve stimulation, Medical research, Desmopressin, Feinstein Institutes for Medical Research, Coagulopathy, Haemophilia, Scientific Advisory Group, Tan, Hemostasis, Nature Communications, Cyclic permutation, Blood, Vagus nerve, Patient, Pharmaceutical industry, Medical device, The New York Times, Cure, Pathway

Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders.

Key Points: 
  • Pathway to Cures (P2C) announced today its investment of $500,000 in Five Liters, a subsidiary of Spark Biomedical, to develop therapies for treating inheritable blood and bleeding disorders.
  • Pathway to Cures, an affiliate of the National Bleeding Disorders Foundation, is a venture philanthropy fund focused on early-stage companies developing cures, therapies, or enabling technologies in support of the inheritable blood and bleeding disorders community.
  • This significant milestone is made possible through Five Liters' collaboration with Northwell Health’s Feinstein Institutes for Medical Research in New York.
  • Dr. Recht is Chief Medical and Scientific Officer at both Pathway to Cures and the National Bleeding Disorders Foundation (NBDF) and chairs the Pathway to Cures Scientific Advisory Group.

New York’s largest health system establishes the Northwell Cardiovascular Institute to transform heart care

Retrieved on: 
Tuesday, October 10, 2023
DEI (Diversity, Equity and Inclusion), Cardiology, General Health, Health, Hospitals, Health Technology, Professional Services, Health Insurance, Transfer, Diagnosis, Telehealth, Cardiovascular disease, Multimedia, Hospital, Microsoft, Teaching, MBA, Faculty, Death, Center for Emergency Medicine of Western Pennsylvania, Research, PAC, Education, COVID, MD, Northwell Health, Equity, Microsoft Teams, Libin Cardiovascular Institute, Heart, Transport, CVI, Facial muscles, Patient, Emergency medicine, North Shore University Hospital, New Yorker, Cardiac catheterization, LabWindows/CVI, Angioplasty, Cardiothoracic surgery, Nursing, Pharmaceutical industry, Management

To enhance the delivery of patient-centered cardiovascular care across its 21-hospital network, Northwell Health announced the creation of the Northwell Cardiovascular Institute (CVI) with a special focus on streamlining patient care, standardizing care delivery, research, and medical education across the health system.

Key Points: 
  • To enhance the delivery of patient-centered cardiovascular care across its 21-hospital network, Northwell Health announced the creation of the Northwell Cardiovascular Institute (CVI) with a special focus on streamlining patient care, standardizing care delivery, research, and medical education across the health system.
  • View the full release here: https://www.businesswire.com/news/home/20231010269308/en/
    Northwell Health announced the creation of the Northwell Cardiovascular Institute to enhance the delivery of patient-centered cardiovascular care across its 21-hospital network.
  • As a leader in cardiovascular disease prevention, diagnosis and treatment, Northwell is dedicated to elevating heart health among New Yorkers.
  • The mission of the Northwell CVI is to create accessible, inclusive and innovative care delivery system with a focus on the cardiovascular patient and care team.

New York State's Largest Employer, Northwell Health, Partners With Gympass to Raise the Standard of Wellbeing for its Employees

Retrieved on: 
Monday, October 16, 2023
AVP, Workforce, MyFitnessPal, Heart, SoulCycle, Strava, Headspace, Life, Research, Quality of life, Sleep, Health insurance, Management, Nursing, Northwell Health

NEW YORK, Oct. 16, 2023 /PRNewswire/ -- Northwell Health, New York State's largest healthcare provider and private employer, is partnering with Gympass, the most loved corporate wellness platform, to set a new standard for employee wellbeing.

Key Points: 
  • Northwell Health's staff has access to Gympass' diverse network of wellness resources meant to help employees move, eat, sleep, think, feel, and live better.
  • With a workforce of more than 85,000 employees, this collaboration showcases how Northwell Health continues to prioritize and support its employees' wellness.
  • "We are thrilled to partner with New York's largest healthcare provider, Northwell Health, to establish a new benchmark for employee wellbeing.
  • To learn more about Northwell Health, visit www.northwell.edu and to learn more about Gympass and its latest offerings, visit www.gympass.com .

Feinstein Institutes secures $4M from NIH to study Black maternal health interventions

Retrieved on: 
Thursday, October 5, 2023
Research, Nursing, Women, Baby, Maternity, Managed Care, Health, Consumer, General Health, Science, Diagnosis, Woman, Incidence, Feinstein Institutes for Medical Research, Multimedia, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Disease, Doctor of Philosophy, Mother, Credit, Death, National Institute of Nursing Research, Bleeding, Pre-eclampsia, Organization, Northwell Health, Risk, Social support, MPH, Mortality, Maternal health, SMM, NINR, Feinstein, Comparison, Medical research, Black, Bangladesh Technical Education Board, Nursing Research, Birth control, MD

Researchers at The Feinstein Institutes for Medical Research at Northwell Health were awarded $4 million from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, to study effective maternal health interventions.

Key Points: 
  • Researchers at The Feinstein Institutes for Medical Research at Northwell Health were awarded $4 million from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, to study effective maternal health interventions.
  • View the full release here: https://www.businesswire.com/news/home/20231005320763/en/
    Feinstein Institutes’ Dr. Stephanie L. Fitzpatrick is co-principal investigator on the new research to study maternal health outcomes interventions.
  • Explore the role of physical activity from study enrollment to 1-year postpartum and subsequent association with maternal health outcomes.
  • In 2022, the health system formed its Center for Maternal Health , led by Dawnette Lewis, MD, MPH .

Laudio Bolsters its Marketing and Sales Leadership Through New C-Suite and Executive Appointments

Retrieved on: 
Thursday, October 5, 2023
Technology, Human Resources, Health Technology, Professional Services, Software, Practice Management, Other Health, Health, Artificial Intelligence, Triage, VC, AI, MD, Workforce management, Nebraska Medicine, Safety, Entrepreneurship, Growth, Northwell Health, SVP, Vipond, Burnout, Cerner, EVP, Management, Laudio/Llodio, Marketing

The company also recently hired Michael Vipond as Executive Vice President of Sales.

Key Points: 
  • The company also recently hired Michael Vipond as Executive Vice President of Sales.
  • These critical hires come on the heels of Laudio raising a $13 million Series B round led by Define Ventures .
  • She brings more than 15 years of marketing experience in the healthcare industry, including a decade leading marketing teams for rapidly-growing, VC-backed companies.
  • As EVP of Sales at Laudio, he will work closely with the rest of the executive leadership team to scale the business, overseeing business development.

Roswell Park Cancer Innovation SurVaxM Granted FDA Fast Track Designation

Retrieved on: 
Saturday, October 14, 2023
Multimedia, M&T Bank, Priority review, Cancer, Glomus tumor, Food, Doctor of Philosophy, Hope, Research, Roswell Park Comprehensive Cancer Center, Texas Oncology, Ride, Multiple myeloma, Roswell, MD, Fred Hutchinson Cancer Research Center, National Cancer Institute, University, Survival, Disease, FDA, Glioblastoma, Accelerated approval (FDA), Fast track (FDA), NDA, Neurosurgery, Overlook Medical Center, Northwell Health, Journal, FTD, Fast Track, Assistant, PSA, Regulation of tobacco by the U.S. Food and Drug Administration, American Journal of Clinical Oncology, Principal investigator, Prostate cancer, Brain, Patient, Cleveland Clinic, Dana–Farber Cancer Institute, Pharmaceutical industry, Medical imaging, Medical device, Online shopping, DRS, Upstate New York, New York University, Roswell Park

BUFFALO, N.Y., Oct. 14, 2023 /PRNewswire-PRWeb/ -- A promising cancer innovation developed at Roswell Park Comprehensive Cancer Center has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA). The designation awarded to MimiVax Inc. provides more extensive and accelerated access to FDA resources for the company's development of the novel cancer immunotherapy SurVaxM, which is now in late-stage trials around the country.

Key Points: 
  • The designation awarded to MimiVax Inc. provides more extensive, accelerated access to FDA resources supporting development of SurVaxM, which originated at Roswell Park.
  • BUFFALO, N.Y., Oct. 14, 2023 /PRNewswire-PRWeb/ -- A promising cancer innovation developed at Roswell Park Comprehensive Cancer Center has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA).
  • From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide.
  • To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit http://www.roswellpark.org , call 1-800-ROSWELL (1-800-767-9355) or email [email protected] .

MimiVax Granted Fast Track Designation from FDA for SurVaxM for Newly Diagnosed Glioblastoma

Retrieved on: 
Thursday, October 12, 2023
Priority review, Texas Oncology, UCSF, Fred Hutchinson Cancer Research Center, Disease, FDA, Science in newly industrialized countries, Accelerated approval (FDA), NDA, Overlook Medical Center, Journal, Northwell Health, FTD, Fast Track, NYU, American Journal of Clinical Oncology, Roswell Park, Patient, Cleveland Clinic, Dana–Farber Cancer Institute, Pharmaceutical industry, Medical device, Glioblastoma

BUFFALO, N.Y., Oct. 12, 2023 /PRNewswire/ -- MimiVax, Inc. , a biotechnology company focused on the development of glioblastoma vaccine therapy, announced today that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to MimiVax's SurVaxM vaccine being studied for the treatment of newly diagnosed glioblastoma (nGBM).

Key Points: 
  • BUFFALO, N.Y., Oct. 12, 2023 /PRNewswire/ -- MimiVax, Inc. , a biotechnology company focused on the development of glioblastoma vaccine therapy, announced today that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to MimiVax's SurVaxM vaccine being studied for the treatment of newly diagnosed glioblastoma (nGBM).
  • MimiVax Granted Fast Track Designation from FDA for SurVaxM for Newly Diagnosed Glioblastoma.
  • MimiVax is focused on completing the Phase 2b SURVIVE study and securing funding necessary to bring SurVaxM through the FDA approval process.
  • "The receipt of Fast Track Designation affirms the importance of new clinical developments of novel therapies to improve the treatment and outcomes for patients with newly diagnosed glioblastoma," said Michael Ciesielski, CEO of MimiVax.

Reigniting the Human Connection Highlights Ways To Achieve Equity in Health Care and Save Lives

Retrieved on: 
Thursday, October 5, 2023
Judgement, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Partnership, Health, Language, Doctor of Philosophy, Burn, Economics, The Human Connection, Cardiology, Communication, Employment, Transport, Medicine, Patient, Appalachian Mountains, Education, Patient safety, Environment, Northwell Health, Doctor of Education, Health equity, Life, Research, Housing, Nursing, Health care, Amazon, Equity

 CHARLESTON, S.C., Oct. 5, 2023 /PRNewswire/ -- Across the country a call-to-action is going out to confront and conquer pervasive inequalities that mar the healthcare landscape. The harsh spotlight on the life or death lessons learned through the pandemic highlighted the fact that when the most vulnerable suffer, the whole nation suffers.

Key Points: 
  • And yet another study found that even at the highest-performing hospitals, patient safety is compromised by racial health disparities.
  • That is the focus of Dr. Jennifer Mieres' book Reigniting the Human Connection: A Pathway to Diversity, Equity, and Inclusion in Healthcare , published by Forbes Books.
  • Mieres ( www.drjennifermieres.com ) is professor of cardiology at the Zucker School of Medicine and SVP Center for Equity of Care, Northwell Health.
  • The authors were involved in the implementation of a nationally recognized diversity and health equity framework at Northwell Health.

Amwell® to Participate in Key HLTH 2023 Engagements

Retrieved on: 
Wednesday, October 4, 2023
Medical Devices, Hospitals, Health Technology, Telemedicine, Virtual Medicine, Health Insurance, Practice Management, Managed Care, Health, General Health, Valley of the Sun Stage Race, Sky, Medicaid, Violence, Las Vegas Convention and Visitors Authority, Ochsner Health System, Health care, Maternal health, Policy, Booth, Las Vegas Convention Center, Sun, Public, Northwell Health, Mother, Organization, Medicare, Amwell, Patient, Digital, CVS Health, Trauma, NYSE, Nursing, Management

Amwell® (NYSE: AMWL), a global leader in hybrid care enablement, is attending the HLTH 2023 conference , Oct. 8-10, in Las Vegas.

Key Points: 
  • Amwell® (NYSE: AMWL), a global leader in hybrid care enablement, is attending the HLTH 2023 conference , Oct. 8-10, in Las Vegas.
  • The session will take place at Booth 3029.
  • The conversation will be in room 216-218 on the second level of the Las Vegas Convention Center.
  • For more information about the organization’s HLTH activities or to request a meeting with an Amwell leader during the event, contact [email protected] , and follow @amwell on X and LinkedIn .

Henry Schein’s Practice Pink Program Continues to Support the Campaign Against Cancer in 2023

Retrieved on: 
Wednesday, October 4, 2023
Fund Raising, Health, Philanthropy, Dental, Oncology, Cancer research, Cancer, Multimedia, KiKa, Organization, Medical Center, Hospital, American Cancer Society, Northwell Health, Breast cancer, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20231003522488/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231003522488/en/
    Practice Pink is an initiative of Henry Schein Cares, the Company’s global corporate social responsibility program.
  • Through Practice Pink, Henry Schein, together with non-governmental organizations and supplier partners across North America and Europe, is helping dental and medical health care professionals raise awareness and support for a cure for breast cancer and other cancers.
  • By offering its customers a variety of pink products, including health care consumables, practice supplies, and apparel, Practice Pink supports important cancer research and prevention efforts.
  • “At Henry Schein, we strongly believe in the potential of public-private partnerships to contribute to a healthier world, and the Henry Schein Cares Practice Pink program exemplifies this belief,” said Maureen Knott, Vice President U.S.